A certificate of analysis is useful only when it answers a procurement question: does this specific batch match the material described on the label? For research peptide certificates of analysis, the difference between a reassuring-looking document and a decision-ready one lies in the batch number, the method used, the reported result and the limits of what was actually tested.
A COA is not a marketing badge, a substitute for method data or evidence of suitability for a particular experiment. It is a batch-linked quality document. Read properly, it helps a researcher assess identity, chromatographic purity and, where reported, peptide content or assay. Read casually, it can encourage false confidence.
All materials discussed here are for laboratory research only. A COA does not establish clinical safety, therapeutic utility, regulatory approval or suitability for human or veterinary use.
What a peptide COA should let you verify
Start with traceability. The document should identify the supplier or testing laboratory, the material name, a batch or lot number, and a date of issue or analysis. The batch number on the certificate should correspond with the product received. If that connection cannot be made, the document may describe a different production run and has limited value for procurement.
The next question is what the stated result means. Many peptide COAs report a chromatographic purity result, commonly obtained by high-performance liquid chromatography (HPLC). Others may include mass spectrometry (MS) data to support molecular identity. These are complementary checks, not interchangeable claims.
A well-presented COA should also state the analytical method, acceptance criteria where available, the result and the unit or calculation basis. The more clearly the document separates these fields, the easier it is to judge whether the claim is relevant to the intended research use.
The four checks to make first
Before comparing products or placing a repeat order, confirm four fundamentals:
- The compound name and batch number match the product and label.
- The document identifies the laboratory or responsible issuer and analysis date.
- The method is named clearly enough to understand what was measured.
- The reported result is tied to a defined specification, rather than a standalone promotional statement.
Purity, identity and content are different questions
These terms are often grouped together, but they address separate aspects of a peptide sample.
Identity asks whether the principal detected material is consistent with the requested peptide. Mass spectrometry is commonly used for this purpose because it measures mass-to-charge signals. A mass consistent with the expected molecular mass can support identity, but it does not by itself map every impurity or establish the proportion of target material in the vial.
Purity asks how much of the detected chromatographic signal is attributed to the main peak under stated HPLC conditions. A chromatogram can reveal the main peak and additional peaks that may represent related species or other components. Reported HPLC area percentage is therefore a useful comparative measure, but it is method-dependent. It is not automatically equivalent to the exact mass fraction of peptide present.
Content, often described as assay or net peptide content, asks how much target material is present by mass. This can be affected by counterions, residual water, salts and the method of quantification. For work that depends on accurate mass balance, a purity figure alone may not answer the practical question. Researchers should look for an explicit assay or content statement and its method, rather than assuming it from a chromatographic percentage.
| Question | Typical supporting method | What it can help show | What it does not establish alone |
|---|---|---|---|
| Is this likely the intended peptide? | Mass spectrometry | Mass consistent with the expected compound | Chromatographic purity or total peptide content |
| Are extra chromatographic signals visible? | HPLC | Relative main-peak area under the stated method | Absolute mass of active material |
| How much target material is present? | Validated quantitative assay | Reported content on the stated basis | Identity and impurity profile without supporting data |
The distinction matters when comparing products labelled with the same nominal vial strength. A high HPLC purity value may be appropriate evidence for one screening workflow, while quantitative work may require additional content information. The right standard depends on the experiment, not on which number looks most impressive.
How to read an HPLC result without overclaiming
An HPLC certificate commonly includes a chromatogram, retention time, main-peak area and a stated purity percentage. Retention time can help identify the reported principal peak within that particular method, but it should not be treated as a universal identity marker. It can vary with column chemistry, mobile phase, gradient, temperature and instrument conditions.
The chromatogram deserves attention beyond the headline percentage. Is there a visible main peak? Are secondary peaks shown? Is the integration clear? A compact chromatogram image will not always permit detailed independent review, but it should be consistent with the reported result and method description.
The term “purity by HPLC” should be read precisely. It generally refers to the proportion of integrated detector response assigned to the principal peak, not a blanket statement that the vial contains that percentage by mass of chemically pure peptide. Ultraviolet response can differ between compounds and impurities. This is one reason a supplier should not present chromatographic purity and peptide content as though they are identical.
What mass spectrometry adds - and where it stops
Mass spectrometry can provide persuasive identity support, particularly when the observed molecular mass aligns with the expected mass of the requested sequence or compound. Depending on the technique and presentation, a report may show charge-state envelopes, a deconvoluted mass or a concise pass statement.
However, an MS match does not provide a complete impurity profile. Closely related variants may be difficult to distinguish in a simple identity check, and a mass result does not quantify all non-peptide components. For procurement, the strongest documentation commonly uses MS and HPLC for their respective purposes: one supports identity and the other examines chromatographic composition.
Ask whether the COA shows actual spectra or chromatograms, or only a written statement. Either may be part of a supplier’s documentation process, but the level of detail affects how much independent scrutiny is possible.
Questions worth asking before you buy
A supplier should be able to explain what its documentation relates to. If a COA is offered, ask whether it is batch-specific, whether testing was performed internally or by an independent laboratory, and which method supports each listed claim. Independence can add confidence, but it does not remove the need to inspect the method, batch match and scope of the analysis.
It is also reasonable to ask whether the sample tested was drawn from the finished batch, whether the test date is available and whether the result applies to the exact format supplied. This is particularly relevant where a catalogue includes vials, cartridges, bundles or other laboratory-use formats. The underlying material may be comparable, but the documentation should not be assumed to transfer across different batches or presentations without confirmation.
For a project with defined analytical requirements, establish the documentation threshold before ordering. A discovery-stage workflow may need clear identity and purity evidence. A method-development or quantitative programme may need more detail on content, counterion form, residual solvents, water content or microbiological controls. Not every COA will include every test, and not every experiment needs every test.
Common warning signs in peptide documentation
Be cautious when a certificate has no lot number, uses a generic product name only, omits the analytical method, or reports a purity figure without a test date or issuer. The same applies to certificates reused across multiple batches without an explanation of equivalence.
Another common issue is vague language such as “laboratory tested” without defining what was tested. That phrase could refer to identity, purity, content, sterility, endotoxin, residual solvents or something else entirely. These analyses answer different questions and should not be inferred from one another.
Finally, avoid treating a clean-looking PDF as proof that every relevant quality attribute has been evaluated. A COA has a defined scope. Its value comes from knowing that scope, matching it to the batch and deciding whether it suits the planned research.
Build COA review into your procurement record
For repeatable laboratory purchasing, retain the COA alongside the order record, product label details and any supplier correspondence. Record the lot number received, date checked and the specific attributes reviewed. This takes little time and makes later comparisons far easier if results vary between batches or a study needs to be revisited.
Researchers evaluating materials from Revitalise Peptides should review the documentation available for the specific product and batch rather than relying on general category statements. Where a result or method is unclear, request clarification before assigning the material to a workflow.
A COA should make the next decision more informed, not more complicated. Review the batch match first, then the method and result, and only then decide whether the documented evidence is proportionate to the research question.